Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA081703-01
Application #
2861922
Study Section
Special Emphasis Panel (ZRG1-SSS-1 (01))
Program Officer
Lohrey, Nancy
Project Start
1999-10-26
Project End
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mayo Clinic, Arizona
Department
Type
DUNS #
City
Scottsdale
State
AZ
Country
United States
Zip Code
85259
Schroeder, Joyce A; Masri, Azzah Al; Adriance, Melissa C et al. (2004) MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation. Oncogene 23:5739-47
Hattrup, Christine L; Fernandez-Rodriguez, Julia; Schroeder, Joyce A et al. (2004) MUC1 can interact with adenomatous polyposis coli in breast cancer. Biochem Biophys Res Commun 316:364-9
Schroeder, Joyce A; Adriance, Melissa C; Thompson, Melissa C et al. (2003) MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene 22:1324-32
Schroeder, Joyce A; Jackson, Leslie F; Lee, David C et al. (2003) Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 81:392-403
Schroeder, Joyce A; Adriance, Melissa C; McConnell, Elizabeth J et al. (2002) ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. J Biol Chem 277:22692-8
Schroeder, J A; Thompson, M C; Gardner, M M et al. (2001) Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem 276:13057-64
Gendler, S J (2001) MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 6:339-53